Hamburg outlines anti-counterfeiting measures; BMS's Orencia measured up to Humira in study;

 @FiercePharma: Pfizer plans IPO for minority stake in animal-health unit--dubbed "Zoetis"--on its way to total spinoff. Report | Follow @FiercePharma

> To fight drug counterfeiting, FDA Commissioner Margaret Hamburg called for increased penalties, global co-operation among regulators, and more supply-chain vigilance on the part of drugmakers. Report

> Bristol-Myers Squibb's ($BMY) Orencia proved comparable to Abbott Laboratories' ($ABT) Humira at treating rheumatoid arthritis patients new to biologic treatments. News

> UCB bolstered its case for four-week dosing of Cimzia in rheumatoid arthritis with data showing comparable efficacy to two-week regimen. Article

> Anti-TNF drugs can increase the risk of shingles by 75% in patients with inflammatory rheumatic diseases, a study found. Item

> U.S. marshals seized unapproved drug products from a company warehouse in Portland, ME. More

> The FDA warned 8 biopharma companies, 6 of them in the Asia Pacific region, for importing drugs into the U.S. without registering their manufacturing plants. Story

> Pharmaxis failed to win the U.K. cost-effectiveness watchdog's backing for its cystic fibrosis drug Bronchitol. Report

Biotech News

 @FierceBiotech: Catalent continues restructuring efforts as it completes work on NC fill-finish plant. News | Follow @FierceBiotech

 @RyanMFierce: My post about how Lilly leads docs to cancer drug trials with iPad app. Article | Follow @RyanMFierce

> Sanofi's Zerhouni rewrites the company playbook on R&D. Report

> Fledgling Foundation Medicine scores a coup with Novartis R&D pact. News

> Otsuka cracks tough TB cases with experimental drug. More

> Lilly chief resolves to stick with high-risk pipeline strategy. Item

Medical Devices News

 @FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev

> Device tax repeal up for House vote today as White House threatens veto. Item

> Mindray snaps up Chinese orthopedics maker for $35.5M. Story

> Report: Panasonic to become major Olympus shareholder with $635M investment. More

CRO News

 @NesaNFierce: Catalent's renovated fill-finish plant in NC is more in-tune with the company's renewed business focus. Article | Follow @NesaNFierce

> Siegfried buys Allied Medical Products for $58M. News

> Medtox's toxicology offerings contribute to LabCorp acquisition, as contract manufacturing shrinks. More

> WuXi PharmaTech speaks out on compound theft by former employee. Article

> Kansas City CROs form alliance to attract outsourcing work to region. Item

Pharma Manufacturing News

> FDA commish suggests drugmakers get on board with track and trace. More

> Sandoz recalls Introvale contraceptives. News

> Indian API maker looks to Asia for cheap energy. Report

Vaccines News

> NewLink Genetics takes the stage at ASCO. Story

> Vax, hormone combo could up efficacy in prostate cancer. Article

> Mapping the way to a Candida vaccine. Item

> Affiris' Parkinson's therapeutic vax starts clinical trials. More

And Finally... Analysis of a pregnant mother's blood and father's saliva yielded a full-genome sequence of their unborn child. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.